{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:25:16Z","timestamp":1784042716952,"version":"3.55.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Highly specific borreliacidal antibodies are induced by infection with\n            <jats:italic>Borrelia burgdorferi<\/jats:italic>\n            , and the immunodominant response during early Lyme disease is specific for an epitope within the 7 amino acids nearest the C terminus of OspC. We evaluated the ability of an enzyme-linked immunosorbent assay (ELISA) based on a synthetic peptide (OspC7) that matched the region to detect the response and compared the sensitivity during early Lyme disease to that for an FDA-approved Western blot. When the optical density value was adjusted to 98% specificity based on the results from testing normal or uncharacterized sera (\n            <jats:italic>n<\/jats:italic>\n            = 236) or sera from patients with blood factors or illnesses that commonly produce antibodies that cross-react with\n            <jats:italic>B. burgdorferi<\/jats:italic>\n            antigens (\n            <jats:italic>n<\/jats:italic>\n            = 77), 115 (73%) of 157 sera from patients likely to have early Lyme disease were positive for immunoglobulin M (IgM) antibodies and 17 (11%) also had IgG antibodies. In addition, the IgM ELISA reactivities and the titers of antibodies detected by a flow cytometric borreliacidal antibody test correlated closely (\n            <jats:italic>r<\/jats:italic>\n            = 0.646). Moreover, the IgM ELISA was significantly more sensitive (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) than the Western blot procedure. The findings therefore confirmed that the peptide IgM ELISA detected OspC borreliacidal antibodies and provided strong evidence that the test can eliminate the necessity for confirming early Lyme disease by a supplementary test such as Western blotting.\n          <\/jats:p>","DOI":"10.1128\/cvi.00079-08","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T01:38:37Z","timestamp":1208396317000},"page":"981-985","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Significantly Improved Accuracy of Diagnosis of Early Lyme Disease by Peptide Enzyme-Linked Immunosorbent Assay Based on the Borreliacidal Antibody Epitope of\n            <i>Borrelia burgdorferi<\/i>\n            OspC"],"prefix":"10.1128","volume":"15","author":[{"given":"Dean A.","family":"Jobe","sequence":"first","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Lovrich","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista E.","family":"Asp","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Mathiason","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"Schell","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Callister","sequence":"additional","affiliation":[{"name":"Microbiology Research Laboratory"},{"name":"Department of Medical Research, Gundersen Lutheran Medical Foundation"},{"name":"Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"},{"name":"Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.3.524-529.1996"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/374395","volume":"187","year":"2003","unstructured":"Bacon, R. M., B. J. Bickerstaff, M. E. Schriefer, R. D. Gilmore, Jr., M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. B. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis.187:1187-1199.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_4_2","first-page":"908","volume":"9","year":"2002","unstructured":"Callister, S. M., D. A. Jobe, W. A. Agger, R. F. Schell, T. J. Kowalski, S. D. Lovrich, and J. A. Marks. 2002. Ability of the borreliacidal antibody test to confirm Lyme disease in clinical practice. Clin. Diagn. Lab. Immunol.9:908-912.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.3.4.399-402.1996"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/167.1.158","volume":"167","year":"1993","unstructured":"Callister, S. M., R. F. Schell, K. L. Case, S. D. Lovrich, and S. P. Day. 1993. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis.167:158-164.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archinte.1994.00420140095012","volume":"154","year":"1994","unstructured":"Callister, S. M., R. F. Schell, L. C. L. Lim, D. A. Jobe, K. L. Case, G. L. Bryant, and P. E. Molling. 1994. Detection of borreliacidal antibodies by flow cytometry: an accurate, highly specific serodiagnostic test for Lyme disease. Arch. Intern. Med.154:1625-1632.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_8_2","first-page":"19","volume":"39","year":"1990","unstructured":"Centers for Disease Control and Prevention. 1990. Case definitions for public health surveillance. MMWR Morb. Mortal. Wkly. Rep.39:19-21.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_9_2","first-page":"590","volume":"44","year":"1995","unstructured":"Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretations from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep.44:590-591.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","first-page":"271","volume":"83","year":"1996","unstructured":"de Silva, A. M., S. R. Telford III, L. R. Brunet, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med.83:271-275.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_11_2","first-page":"95","volume":"4","year":"1991","unstructured":"Fields, C. G., D. H. Lloyd, R. L. MacDonald, K. M. Otteson, and R. L. Noble. 1991. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res.4:95-101.","journal-title":"Peptide Res."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1073\/pnas.0306845101","volume":"101","year":"2004","unstructured":"Grimm, D., K. Tilly, R. Byram, P. E. Stewart, J. G. Krum, D. M. Bueschel, T. G. Schwan, P. F. Policastro, A. F. Elias, and P. A. Rosa. 2004. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci.101:3142-3147.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.2070-2073.2002"},{"key":"e_1_3_2_14_2","first-page":"37","volume":"182","year":"1993","unstructured":"Jauris-Heipke, S., R. Fuchs, M. Motz, V. Preac-Mursic, E. Schwab, E. Soutschek, G. Will, and B. Wilske. 1993. Genetic heterogeneity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Med. Microbiol. Immunol.182:37-50.","journal-title":"Med. Microbiol. Immunol."},{"key":"e_1_3_2_15_2","first-page":"573","volume":"10","year":"2003","unstructured":"Jobe, D. A., S. D. Lovrich, R. F. Schell, and S. M. Callister. 2003. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease. Clin. Diagn. Lab. Immunol.10:573-578.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.12.3997-4004.1999"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/315862","volume":"182","year":"2000","unstructured":"Liang, F. T., E. Aberger, M. Cinco, L. Gern, C. M. Hu, Y. N. Lobet, M. Ruscio, P. E. Voet, Jr., V. E. Weynants, and M. T. Philipp. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis.182:1455-1462.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.12.3990-3996.1999"},{"key":"e_1_3_2_19_2","first-page":"746","volume":"12","year":"2005","unstructured":"Lovrich, S. D., D. A. Jobe, R. F. Schell, and S. M. Callister. 2005. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters. Clin. Diagn. Lab. Immunol.12:746-751.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.5.1735-1739.2000"},{"key":"e_1_3_2_21_2","first-page":"37","volume":"28","year":"2005","unstructured":"Marangoni, A., M. Sparacino, V. Mondarini, F. Cavrini, E. Storni, M. Donati, R. Cevenini, and V. Sambri. 2005. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol.28:37-43.","journal-title":"New Microbiol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.12.3474-3479.1998"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.9.4073-4079.1998"},{"key":"e_1_3_2_24_2","first-page":"924","volume":"11","year":"2004","unstructured":"Mogilyansky, E., C. C. Loa, M. E. Adelson, E. Mordechai, and R. C. Tilton. 2004. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol.11:924-929.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/174.4.739","volume":"174","year":"1996","unstructured":"Padilla, M. L., S. M. Callister, R. F. Schell, G. L. Bryant, D. A. Jobe, S. D. Lovrich, B. K. DuChateau, and J. R. Jensen. 1996. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis.174:739-746.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.7.1733-1738.1994"},{"key":"e_1_3_2_27_2","first-page":"193","volume":"67","year":"1985","unstructured":"Petrakis, N. L. 1985. Biologic banking in cohort studies, with special reference to blood. NCI Monogr.67:193-198.","journal-title":"NCI Monogr."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/515382","volume":"178","year":"1998","unstructured":"Rousselle, J. C., S. M. Callister, R. F. Schell, S. D. Lovrich, D. A. Jobe, J. A. Marks, and C. A. Wieneke. 1998. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J. Infect. Dis.178:733-741.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.92.7.2909","volume":"92","year":"1995","unstructured":"Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA92:2909-2913.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1469-0691.2006.01448.x","volume":"12","year":"2006","unstructured":"Smismans, A., V. J. Goossens, E. Nulens, and C. A. Bruggeman. 2006. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin. Microbiol. Infect.12:648-655.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","year":"1998","unstructured":"Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, and D. S. Krause. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med.339:209-215.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.10.2570-2576.1993"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01950-05"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.313-317.2000"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00079-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00079-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:40:24Z","timestamp":1627591224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00079-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1128\/CVI.00079-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00079-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"2008-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-04-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}